TVARDI THERAPEUTICS, INC. Accumulated Other Comprehensive Income
TVARDI THERAPEUTICS, INC. (TVRD) had Accumulated Other Comprehensive Income of $1.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $7.00K.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$13.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $8.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$13.00K 10-Q · filed 2025-08-14 |
| 2024-09-30 | -$25.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$121.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$191.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$260.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | -$439.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$730.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$1.10M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$1.67M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$2.15M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$2.05M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$1.72M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$358.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$5.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $12.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $73.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $363.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $635.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$68.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $170.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $153.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $165.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $73.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$114.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $13.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$57.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$114.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$70.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $40.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$13.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $24.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $3.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $20.00K 10-Q · filed 2017-11-02 |
| 2016-06-30 | $41.00K 10-Q · filed 2017-08-03 |
| 2016-03-31 | $4.00K 10-Q · filed 2017-05-04 |
| 2015-12-31 | -$35.00K 10-Q · filed 2017-11-02 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |